These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 4082802

  • 21. [Prevention of postoperative thromboembolism with a heparin- dihydroergotamine combination].
    Sándor T, Lászlo E, Magyary F, Turcsányi G, Hetényi L, Izinger E.
    Orv Hetil; 1984 Feb 26; 125(9):519-24. PubMed ID: 6700990
    [No Abstract] [Full Text] [Related]

  • 22. Vascular spasm and gangrene during heparin-dihydro-ergotamine prophylaxis.
    Cunningham M, de Torrenté A, Ekoé JM, Ackermann JP, Humair L.
    Br J Surg; 1984 Nov 26; 71(11):829-31. PubMed ID: 6498453
    [Abstract] [Full Text] [Related]

  • 23. [Postoperative changes in hemostasis by heparin/dihydroergotamine prevention].
    Briel RC.
    Fortschr Med; 1983 May 12; 101(18):846-9. PubMed ID: 6862345
    [Abstract] [Full Text] [Related]

  • 24. [Complications following preventive treatment of thromboembolism with Dihydergot-heparin].
    Andersen KH, Jeppesen IS.
    Ugeskr Laeger; 1989 Aug 14; 151(33):2072-5. PubMed ID: 2672498
    [Abstract] [Full Text] [Related]

  • 25. [Heparin-dihydergot or heparin alone in thrombosis prophylaxis?].
    Koppenhagen K, Matthes M.
    Med Welt; 1982 Feb 12; 33(6):216-23. PubMed ID: 7070283
    [No Abstract] [Full Text] [Related]

  • 26. [Risk of arterial vasospasms caused by the administration of dihydroergotamine (Dihytamin)--a case report].
    Lange T.
    Anaesthesiol Reanim; 1987 Feb 12; 12(3):177-81. PubMed ID: 3620072
    [No Abstract] [Full Text] [Related]

  • 27. [5 years' general drug prevention of thromboembolism in general surgery. Comparison of personal experiences with results from the literature].
    Voigt J, Lennert K, Hedderich J.
    Fortschr Med; 1984 May 24; 102(20):562-4. PubMed ID: 6735335
    [Abstract] [Full Text] [Related]

  • 28. Combination dihydroergotamine mesylate and heparin sodium with lidocaine HCl. Pharmacokinetics, mechanism of action, clinical efficacy, and adverse effects.
    Barone JA, Raia JJ, Levy DB.
    Pharmacotherapy; 1986 May 24; 6(4 Pt 2):3S-11S. PubMed ID: 3534804
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Diagnosis and therapy of ergotism following the use of heparin-DHE in thrombosis prevention].
    Wiesmann W, Peters PE, Irskens U, Schwering H.
    Rofo; 1987 Oct 24; 147(4):446-9. PubMed ID: 2825270
    [Abstract] [Full Text] [Related]

  • 32. [Postoperative hematomas and wound healing disorders with preventive low dose use of heparin and heparin/dihydroergotamine].
    Briel RC, Bögelspacher HR, Neeser E, Kunz S.
    Med Welt; 1981 May 08; 32(19):732-4. PubMed ID: 7231135
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Review of the Multicenter Trial Committee report: a prospective, randomized study on the prophylaxis of postoperative deep venous thrombosis.
    Comerota AJ.
    Pharmacotherapy; 1986 May 08; 6(4 Pt 2):18S-22S. PubMed ID: 3534803
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in general surgery].
    Schott G.
    Z Gesamte Inn Med; 1984 Sep 01; 39(17):431-5. PubMed ID: 6506818
    [Abstract] [Full Text] [Related]

  • 40. [Effectiveness-risk ratio of heparin-dihydroergotamine].
    Kakkar VV.
    Dtsch Med Wochenschr; 1983 Oct 07; 108(40):1536-7. PubMed ID: 6617512
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.